arrow_back Back to App

More Research and Education on Uterine Fibroids

This act aims to boost research and awareness regarding uterine fibroids, a condition affecting millions of women. It allocates funding for research, data collection on Medicaid and CHIP treatments, and public and professional education programs. The goal is to improve diagnosis and treatment, thereby reducing suffering and costs associated with the condition.
Key points
Increased funding for research into uterine fibroids to better understand their causes and find more effective treatments.
Launch of public education programs to raise awareness about uterine fibroids, their symptoms, and available treatment options, including non-invasive ones.
Collection of data on uterine fibroid treatments under Medicaid and CHIP programs to assess service utilization.
Support for healthcare providers in implementing evidence-based care for uterine fibroids, with a focus on high-risk groups.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_2007
Sponsor: Rep. Clarke, Yvette D. [D-NY-9]
Process start date: 2021-03-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2007.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-03-18.

What are the main provisions?

Key points include:

  • Increased funding for research into uterine fibroids to better understand their causes and find more effective treatments.
  • Launch of public education programs to raise awareness about uterine fibroids, their symptoms, and available treatment options, including non-invasive ones.
  • Collection of data on uterine fibroid treatments under Medicaid and CHIP programs to assess service utilization.
  • Support for healthcare providers in implementing evidence-based care for uterine fibroids, with a focus on high-risk groups.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Clarke, Yvette D. [D-NY-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health